Skip to content

Clinical trials

Completed Phase 3 Diabetic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Phase: Phase 3 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20033
20044
20056
20063
20073
20083
20104
20114
20161
20171
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.6
UCB Pharma5
Helixmith Co., Ltd.3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
MEDA Pharma GmbH & Co. KG2
Pfizer2
Arafarma Group, S.A.1
Avanir Pharmaceuticals1
Bukwang Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies46
Pain10
Diabetes Mellitus6
Peripheral Nervous System Diseases6
Diabetes Mellitus, Type 13
Diabetes Mellitus, Type 23
Neuralgia3
Polyneuropathies2
Chronic Pain1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.